Intravascular lymphoma, also known as intravascular lymphomatosis, corresponds to a rare variant of extranodal diffuse large B cell lymphoma that affects small and medium-sized vessels and has no specific clinical or laboratory findings. CNS and skin manifestations are the most common forms, however, any organ may be involved 1,2,6.
Intravascular lymphoma usually affects elderly patients in their 6th to 7th decades of life, with a male-to-female ratio of 1:2 3.
It has non-specific clinical features. Encephalopathy, subacute progressive neurological deficits (depending on the location of vascular occlusions), cutaneous involvement or fever of unknown origin have been reported as common clinical features in those patients 3,4.
A mild to moderate elevation of CSF protein is usually present 4.
The reason why lymphoma cells tend to stay in the intravascular space in IVL is a consequence of the absence of CD29 (β1 integrin) and CD54 (ICAM-1) surface ligands, which probably disable them from diapedesis across the endothelium 2.
The diagnosis of IVL is made postmortem in over 50% of the cases 2.
Angiography (DSA), CT and MRI often show evidence of multiple
vascular occlusions and stroke as nonspecific multifocal abnormalities 4-6.
- T2/FLAIR: hypersignal abnormalities in a dynamic pattern (resolution of some and the new appearance of others) 5
- DWI/ADC: restriction areas in a dynamic pattern 5
- T1 C+ (Gd): a persistent mass-like enhancement may be noted in proximity to the T2 or DWI changes. Different patterns of parenchymal and meningeal enhancement may be seen 5,6
Treatment and prognosis
Intravascular lymphoma usually has a rapidly fatal outcome, with patient overall survival lasting only a few months. Intravascular lymphoma is sensitive to systemic chemotherapy, however, the treatment still remains suboptimal due to the rarity of this disorder and the difficulty to establish a diagnosis in time 2.
History and etymology
This condition was first described in Germany by L Pfleger and J Tappeiner in 1959 and designated as angioendotheliomatosis proliferans systemisata 4.
Entities which promote multifocal brain lesions associated with a rapidly
progressive dementia should be considered as a differential diagnosis (e.g. stroke, primary angiitis of the CNS, infection and neoplasia) 4,5.
- 1. Jethwani DP, Yadav R, Chickabasaviah YT. A 58-year-old lady with progressive neurological syndrome: Presence of an intravascular lymphoma. Neurol India. 2015;63 (2): 225-9. doi:10.4103/0028-3886.156288 - Pubmed citation
- 2. Fonkem E, Lok E, Robison D et-al. The natural history of intravascular lymphomatosis. Cancer Med. 2014;3 (4): 1010-24. doi:10.1002/cam4.269 - Free text at pubmed - Pubmed citation
- 3. Gan LP, Ooi WS, Lee HY et-al. A case of large B-cell intravascular lymphoma in the brain. Surg Neurol Int. 2013;4 (1): 99. doi:10.4103/2152-7806.115709 - Free text at pubmed - Pubmed citation
- 4. Williams RL, Meltzer CC, Smirniotopoulos JG et-al. Cerebral MR imaging in intravascular lymphomatosis. AJNR Am J Neuroradiol. 1998;19 (3): 427-31. Pubmed citation
- 5. Baehring JM, Henchcliffe C, Ledezma CJ et-al. Intravascular lymphoma: magnetic resonance imaging correlates of disease dynamics within the central nervous system. J. Neurol. Neurosurg. Psychiatr. 2005;76 (4): 540-4. doi:10.1136/jnnp.2003.033662 - Free text at pubmed - Pubmed citation
- 6. Slone HW, Blake JJ, Shah R et-al. CT and MRI findings of intracranial lymphoma. AJR Am J Roentgenol. 2005;184 (5): 1679-85. doi:10.2214/ajr.184.5.01841679 - Pubmed citation